Notice of affirmative preliminary CVD determination, and alignment of the final CVD determination with the AD investigation of hard empty capsules from India, (C-533-935)

1. On 03/31/2025, Commerce published in the Federal Register its affirmative preliminary determination in the countervailing duty (CVD) investigation of hard empty capsules from India (subject merchandise) (90 FR 14237). Additionally, Commerce has aligned the deadline for the final determination in the CVD investigation with the deadline for the final determination in the companion antidumping duty investigation of the same merchandise, currently scheduled to be issued no later than 08/05/2025. 2. The merchandise covered by this investigation is described in message 4330402, dated 11/25/2024. 3. This proceeding has been assigned case number C-533-935. 4. Cash Deposits for the companies identified below. 4a. CBP shall suspend liquidation of subject merchandise entered, or withdrawn from warehouse, for consumption on or after 03/31/2025 (the date of publication of the preliminary determination), and shall require, for such entries, a cash deposit equal to the percentages of entered value for the producer(s) and/or exporter(s) listed below. Producer and/or Exporter: ACG Associated Capsules Private Limited; ACG Pam Pharma Technologies Private Limited; ACG Universal Capsules Private Limited Case Number: C-533-935-001 Cash Deposit: 9.95 percent Producer and/or Exporter: All Others Case Number: C-533-935-000 Cash Deposit Rate: 9.95 percent 5. If there are any questions by the public regarding this message, please contact the Call Center for the Office of AD/CVD Operations, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, at (202) 482-0984. CBP ports should submit their inquiries through authorized CBP channels only. (This message was generated by OII:KS.) 6. There are no restrictions on the release of this information. Alexander Amdur